4) Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R. and Dagenais, G., Effests of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N. Engl. J. Med., 342, 145-153 (2000).
5) Rakugi, H. and Ogihara, T., Angiotensine converting enzyme inhibitor. J. Clinical and Experimental Medicine, 202, 693-698 (2002).